US pharmaceutical exports to Russia doubled in H1 2025
US pharmaceutical exports to Russia doubled in the first half of 2025 to USD 109.8 million, with finished medicines remaining the leading category of US exports to the country.
US pharmaceutical exports to Russia doubled in the first half of 2025, reaching USD 109.8 million. June alone saw a 4.3-fold rise to USD 10.8 million.
Year-on-year shipments of finished medicines increased 6.7 times to USD 9.9 million; vaccines and sera shipments reached USD 9.6 million.
Pharmaceuticals remain the leading category of US exports to Russia.
Source: RBC.
Expertise
A full spectrum of services — from intellectual property and tax to financial markets, digital assets and corporate transactions.
Intellectual Property & IT
IP law and technology: IT products, trademarks and patents, protection of exclusive rights.
Tax & Finance
Tax planning and financial analytics: burden optimization, audit, modelling and management reporting.
Financial Markets, Digital Assets & Investment
Financial markets, digital assets and investment: licensing, crypto regulation, securities and DFA issuances.
Corporate Law & M&A
Corporate transactions: company incorporation and reorganization, M&A, due diligence, governance and disputes.